267 related articles for article (PubMed ID: 28288458)
1. Gastric Acid Suppression Is Associated with an Increased Risk of Adverse Outcomes in Inflammatory Bowel Disease.
Shah R; Richardson P; Yu H; Kramer J; Hou JK
Digestion; 2017; 95(3):188-193. PubMed ID: 28288458
[TBL] [Abstract][Full Text] [Related]
2. Drugs that inhibit gastric acid secretion may alter the course of inflammatory bowel disease.
Juillerat P; Schneeweiss S; Cook EF; Ananthakrishnan AN; Mogun H; Korzenik JR
Aliment Pharmacol Ther; 2012 Aug; 36(3):239-47. PubMed ID: 22670722
[TBL] [Abstract][Full Text] [Related]
3. Acid suppression medications reduce risk of oesophageal adenocarcinoma in Barrett's oesophagus: a nested case-control study in US male veterans.
Tan MC; El-Serag HB; Yu X; Thrift AP
Aliment Pharmacol Ther; 2018 Aug; 48(4):469-477. PubMed ID: 29956826
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology and Long-term Outcome of Inflammatory Bowel Disease Diagnosed at Elderly Age-An Increasing Distinct Entity?
Jeuring SF; van den Heuvel TR; Zeegers MP; Hameeteman WH; Romberg-Camps MJ; Oostenbrug LE; Masclee AA; Jonkers DM; Pierik MJ
Inflamm Bowel Dis; 2016 Jun; 22(6):1425-34. PubMed ID: 26933752
[TBL] [Abstract][Full Text] [Related]
5. Regular Use of Proton Pump Inhibitor and the Risk of Inflammatory Bowel Disease: Pooled Analysis of 3 Prospective Cohorts.
Xia B; Yang M; Nguyen LH; He Q; Zhen J; Yu Y; Di M; Qin X; Lu K; Kuo ZC; He Y; Zhang C; Meng W; Yuan J
Gastroenterology; 2021 Dec; 161(6):1842-1852.e10. PubMed ID: 34389338
[TBL] [Abstract][Full Text] [Related]
6. Upfront Combination Therapy, Compared With Monotherapy, for Patients Not Previously Treated With a Biologic Agent Associates With Reduced Risk of Inflammatory Bowel Disease-related Complications in a Population-based Cohort Study.
Targownik LE; Benchimol EI; Bernstein CN; Singh H; Lix L; Tennakoon A; Leung S; Aviña A; Coward S; Jones J; Kaplan G; Murthy SK; Nguyen GC; Peña-Sánchez JN
Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1788-1798.e2. PubMed ID: 30448599
[TBL] [Abstract][Full Text] [Related]
7. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency.
Lam JR; Schneider JL; Zhao W; Corley DA
JAMA; 2013 Dec; 310(22):2435-42. PubMed ID: 24327038
[TBL] [Abstract][Full Text] [Related]
8. Proton Pump Inhibitor Use Before and After a Diagnosis of Inflammatory Bowel Disease.
Singh N; Nugent Z; Singh H; Shaffer SR; Bernstein CN
Inflamm Bowel Dis; 2023 Dec; 29(12):1871-1878. PubMed ID: 36790051
[TBL] [Abstract][Full Text] [Related]
9. Use of Proton Pump Inhibitors vs Histamine 2 Receptor Antagonists for the Risk of Gastric Cancer: Population-Based Cohort Study.
Shin GY; Park JM; Hong J; Cho YK; Yim HW; Choi MG
Am J Gastroenterol; 2021 Jun; 116(6):1211-1219. PubMed ID: 34074826
[TBL] [Abstract][Full Text] [Related]
10. Risk of Surgery and Mortality in Elderly-onset Inflammatory Bowel Disease: A Population-based Cohort Study.
Nguyen GC; Bernstein CN; Benchimol EI
Inflamm Bowel Dis; 2017 Feb; 23(2):218-223. PubMed ID: 27997435
[TBL] [Abstract][Full Text] [Related]
11. Associations of Acid Suppressive Therapy With Cardiac Mortality in Heart Failure Patients.
Yoshihisa A; Takiguchi M; Kanno Y; Sato A; Yokokawa T; Miura S; Abe S; Misaka T; Sato T; Suzuki S; Oikawa M; Kobayashi A; Yamaki T; Kunii H; Nakazato K; Suzuki H; Saitoh SI; Takeishi Y
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28512114
[TBL] [Abstract][Full Text] [Related]
12. Increased risk of pneumonia among patients with inflammatory bowel disease.
Long MD; Martin C; Sandler RS; Kappelman MD
Am J Gastroenterol; 2013 Feb; 108(2):240-8. PubMed ID: 23295276
[TBL] [Abstract][Full Text] [Related]
13. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
Burisch J
Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
[TBL] [Abstract][Full Text] [Related]
14. Statins Associated With Decreased Risk of New Onset Inflammatory Bowel Disease.
Ungaro R; Chang HL; Côté-Daigneault J; Mehandru S; Atreja A; Colombel JF
Am J Gastroenterol; 2016 Oct; 111(10):1416-1423. PubMed ID: 27296939
[TBL] [Abstract][Full Text] [Related]
15. No Increase in Risk of Acute Myocardial Infarction in Privately Insured Adults Prescribed Proton Pump Inhibitors vs Histamine-2 Receptor Antagonists (2002-2014).
Landi SN; Sandler RS; Pate V; Lund JL
Gastroenterology; 2018 Mar; 154(4):861-873.e6. PubMed ID: 29122546
[TBL] [Abstract][Full Text] [Related]
16. Risk of spontaneous bacterial peritonitis associated with gastric Acid suppression.
Chang SS; Lai CC; Lee MG; Lee YC; Tsai YW; Hsu WT; Lee CC
Medicine (Baltimore); 2015 Jun; 94(22):e944. PubMed ID: 26039135
[TBL] [Abstract][Full Text] [Related]
17. Dual therapy with infliximab and immunomodulator reduces one-year rates of hospitalization and surgery among veterans with inflammatory bowel disease.
Abraham NS; Richardson P; Castillo D; Kane SV
Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1281-7. PubMed ID: 23792295
[TBL] [Abstract][Full Text] [Related]
18. Incidence and Clinical Outcomes of Inflammatory Bowel Disease in South Korea, 2011-2014: A Nationwide Population-Based Study.
Jung YS; Han M; Kim WH; Park S; Cheon JH
Dig Dis Sci; 2017 Aug; 62(8):2102-2112. PubMed ID: 28593437
[TBL] [Abstract][Full Text] [Related]
19. Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit.
MacLaren R; Reynolds PM; Allen RR
JAMA Intern Med; 2014 Apr; 174(4):564-74. PubMed ID: 24535015
[TBL] [Abstract][Full Text] [Related]
20. Use of gastric acid-suppressive agents increases the risk of dementia in patients with upper gastrointestinal disease: A population-based retrospective cohort study.
Lin HC; Huang KT; Lin HL; Uang YS; Ho Y; Keller JJ; Wang LH
PLoS One; 2021; 16(3):e0249050. PubMed ID: 33765029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]